Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Considerations for the development and practice of cascade impaction testing, including a mass balance failure investigation tree.

Literature DB >> 14572321

Considerations for the development and practice of cascade impaction testing, including a mass balance failure investigation tree.

Dave Christopher¹, Paul Curry, Bill Doub, Kenneth Furnkranz, Martin Lavery, Karl Lin, Svetlana Lyapustina, Jolyon Mitchell, Brian Rogers, Helen Strickland, Terrence Tougas, Yi Tsong, Bruce Wyka.

Abstract

Entities: Disease

Mesh：

Substances：
Aerosols

Year: 2003 PMID： 14572321 DOI： 10.1089/089426803769017604

Source DB: PubMed Journal: J Aerosol Med ISSN： 0894-2684

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Measurement of drug in small particles from aqueous nasal sprays by Andersen Cascade Impactor.

Authors: William H Doub; Wallace P Adams; Anna M Wokovich; John C Black; Meiyu Shen; Lucinda F Buhse
Journal: Pharm Res Date: 2012-07-03 Impact factor: 4.200

2. Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated andersen cascade impactors (ACIs): part 1.

Authors: Jolyon P Mitchell; Mark W Nagel; Cathy C Doyle; Rubina S Ali; Valentina I Avvakoumova; J David Christopher; Jorge Quiroz; Helen Strickland; Terrence Tougas; Svetlana Lyapustina
Journal: AAPS PharmSciTech Date: 2010-05-18 Impact factor: 3.246

3. Cascade impactor (CI) mensuration--an assessment of the accuracy and precision of commercially available optical measurement systems.

Authors: Frank Chambers; Aziz Ali; Jolyon Mitchell; Christopher Shelton; Steve Nichols
Journal: AAPS PharmSciTech Date: 2010-03-23 Impact factor: 3.246

4. Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated andersen cascade impactors (ACIs): part 2--investigation of bias in extra-fine mass fraction with AIM-HRT impactor.

5. Particle size analysis: AAPS workshop report, cosponsored by the Food and Drug Administration and the United States Pharmacopeia.

Authors: Diane J Burgess; Eric Duffy; Frank Etzler; Anthony J Hickey
Journal: AAPS J Date: 2004-08-22 Impact factor: 4.009

6. Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols: part 2--evaluation of a method for determining equivalence.

Authors: David Christopher; Wallace P Adams; Douglas S Lee; Beth Morgan; Ziqing Pan; Gur Jai Pal Singh; Yi Tsong; Svetlana Lyapustina
Journal: AAPS PharmSciTech Date: 2007-01-19 Impact factor: 3.246

7. Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols. Part 3. Final report on a statistical procedure for determining equivalence.

Authors: David Christopher; Wallace Adams; Anthony Amann; Craig Bertha; Peter R Byron; William Doub; Craig Dunbar; Walter Hauck; Svetlana Lyapustina; Jolyon Mitchell; Beth Morgan; Steve Nichols; Ziqing Pan; Gur Jai Pal Singh; Terrence Tougas; Yi Tsong; Ron Wolff; Bruce Wyka
Journal: AAPS PharmSciTech Date: 2007-11-02 Impact factor: 3.246

Review 8. In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.

Authors: Jolyon Mitchell; Steve Newman; Hak-Kim Chan
Journal: AAPS PharmSciTech Date: 2007-12-21 Impact factor: 3.246

9. The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation.

Authors: J P Mitchell; M W Nagel; V Avvakoumova; H MacKay; R Ali
Journal: AAPS PharmSciTech Date: 2009-03-12 Impact factor: 3.246

Review 10. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors: Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal: Biomaterials Date: 2019-09-14 Impact factor: 12.479